May 19th, 2020 • 19 mins 32 secs • Download (26.8 MB) • Link with Timestamp
Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.